$369.84
-1.53-0.41%
In chiusura: -
$358.00
-11.84-3.20%
After hour: Aug 15, 5:38 PM EDT
Comments
Loading...
Attività di insider trading
Tieni traccia delle ultime attività di insider trading Madrigal Pharmaceuticals. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Madrigal Pharmaceuticals.
Cos'è l'attività interna?
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Cosa stanno facendo gli Madrigal Pharmaceuticals Inc addetti ai lavori?
A Madrigal Pharmaceuticals Inc, la recente attività interna ha attirato l'attenzione. Negli ultimi 30 giorni, gli addetti ai lavori hanno riferito di aver venduto un totale di - azioni del valore di -, nel frattempo, gli addetti ai lavori hanno segnalare nessun acquisto negli ultimi 30 giorni.
Notevoli acquisti e vendite recenti di insider
Non ci sono stati acquisti o vendite da parte di Insider negli ultimi 90 giorni.
Statistiche sulla proprietà per Madrigal Pharmaceuticals Inc
Numero di azioni emesse
22.289M
Azioni possedute dagli insider
9.045M
Percentuale posseduta dagli Insider
40.7%
Azioni possedute dagli investitori istituzionali
11.777M
Percentuale posseduta dagli investitori istituzionali
53.0%
Aug 15, 2025 | DIRECTOR | 0.00 | $190.83 | -$3.49M | SELL-OPTIONS | 0.00% | 2.63K | Aug 15 | ||
Aug 13, 2025 | DIRECTOR | 0.00 | $189.85 | -$46.60M | SELL-OPTIONS | 0.00% | 842.70K | Aug 13 | ||
Aug 13, 2025 | DIRECTOR | 0.00 | $182.38 | -$16.19M | SELL-OPTIONS | 0.00% | 842.70K | Aug 11 - Aug 12 | ||
Aug 13, 2025 | DIRECTOR | 0.00 | $182.38 | -$16.07M | SELL-OPTIONS | 0.00% | 1.12M | Aug 11 - Aug 12 | ||
Jul 22, 2025 | DIRECTOR | 0.00 | $179.73 | -$340.56K | SELL-OPTIONS | 0.00% | 1.12M | Jul 18 | ||
Jul 22, 2025 | DIRECTOR | 0.00 | $179.74 | -$476.81K | SELL-OPTIONS | 0.00% | 842.70K | Jul 18 | ||
Jul 18, 2025 | DIRECTOR | 0.00 | $181.32 | -$9.93M | SELL-OPTIONS | 0.00% | 842.70K | Jul 16 - Jul 17 | ||
Jul 18, 2025 | DIRECTOR | 0.00 | $181.32 | -$10.00M | SELL-OPTIONS | 0.00% | 1.12M | Jul 16 - Jul 17 | ||
Mar 14, 2025 | DIRECTOR | 0.00 | $205.72 | -$3.80M | SELL-OPTIONS | 0.00% | 371.08K | Mar 12 - Mar 13 | ||
Mar 12, 2025 | SVP AND CFO | -258.00 | $323.04 | -$83.34K | SELL | -2.41% | 10.44K | Mar 10 | ||
Mar 07, 2025 | SENIOR VP, CHIEF PHARMA DEV. | 2.06K | $214.41 | -$3.58M | SELL-OPTIONS | 55.28% | 5.79K | Mar 05 | ||
Mar 05, 2025 | GENERAL COUNSEL | -415.00 | $335.00 | -$139.03K | SELL | -5.39% | 7.29K | Mar 03 | ||
Mar 05, 2025 | SVP AND CFO | -1.96K | $324.96 | -$637.25K | SELL | -22.10% | 6.91K | Mar 03 | ||
Mar 05, 2025 | CHIEF COMMERCIAL OFFICER | -1.83K | $325.98 | -$597.84K | SELL | -17.57% | 8.60K | Mar 03 | ||
Mar 04, 2025 | SENIOR VP, CHIEF PHARMA DEV. | -1.23K | $341.07 | -$418.49K | SELL | -24.76% | 3.73K | Feb 28 | ||
Feb 28, 2025 | DIRECTOR | 0.00 | $215.18 | -$4.09M | SELL-OPTIONS | 0.00% | 1.91K | Feb 27 | ||
Feb 28, 2025 | DIRECTOR | 0.00 | $211.35 | -$5.80M | SELL-OPTIONS | 0.00% | 1.91K | Feb 27 | ||
Jan 27, 2025 | CHIEF COMMERCIAL OFFICER | -347.00 | $335.24 | -$116.33K | SELL | -3.22% | 10.44K | Jan 24 | ||
Jan 27, 2025 | PRESIDENT AND CEO | -1.58K | $335.24 | -$531.02K | SELL | -2.83% | 54.30K | Jan 24 | ||
Jan 27, 2025 | PRES., R&D, AND CMO | -648.00 | $335.24 | -$217.24K | SELL | -0.06% | 1.11M | Jan 24 | ||
Jan 27, 2025 | SENIOR VP, CHIEF PHARMA DEV. | -103.00 | $335.24 | -$34.53K | SELL | -2.04% | 4.96K | Jan 24 | ||
Jan 17, 2025 | GENERAL COUNSEL | -277.00 | $273.41 | -$75.73K | SELL | -3.47% | 7.71K | Jan 17 | ||
Jan 17, 2025 | SENIOR VP, CHIEF PHARMA DEV. | -442.00 | $273.41 | -$120.85K | SELL | -8.04% | 5.06K | Jan 17 | ||
Jan 17, 2025 | PRES., R&D, AND CMO | -1.69K | $273.41 | -$461.79K | SELL | -0.15% | 1.11M | Jan 17 | ||
Dec 05, 2024 | DIRECTOR | -3.60K | $315.31 | -$1.14M | SELL | -22.70% | 12.26K | Dec 03 | ||
Nov 27, 2024 | DIRECTOR | -3.40K | $350.30 | -$1.19M | SELL | -17.65% | 15.86K | Nov 25 | ||
Nov 22, 2024 | CHIEF COMMERCIAL OFFICER | -688.00 | $316.92 | -$218.04K | SELL | -6.00% | 10.79K | Nov 21 | ||
Nov 08, 2024 | — | 0.00 | $178.68 | -$1.71M | SELL-OPTIONS | 0.00% | 11.01K | Nov 07 | ||
Nov 05, 2024 | — | 0.00 | $154.15 | -$1.47M | SELL-OPTIONS | 0.00% | 11.01K | Nov 01 | ||
Sep 11, 2024 | PRESIDENT AND CEO | -6.36K | $243.83 | -$1.55M | SELL | -10.22% | 55.89K | Sep 09 | ||
Jun 18, 2024 | SENIOR VP, CHIEF PHARMA DEV. | 0.00 | $183.55 | -$366.53K | SELL-OPTIONS | 0.00% | 5.50K | Jun 14 | ||
Jun 14, 2024 | SENIOR VP, CHIEF PHARMA DEV. | 0.00 | $186.46 | -$394.16K | SELL-OPTIONS | 0.00% | 5.50K | Jun 12 | ||
May 23, 2024 | SENIOR VP, CHIEF PHARMA DEV. | -1.04K | $231.34 | -$239.67K | SELL | -15.85% | 5.50K | May 21 | ||
May 16, 2024 | — | 0.00 | $157.95 | -$2.47M | SELL-OPTIONS | 0.00% | 431.36K | May 14 | ||
Apr 10, 2024 | PRES., R&D, AND CMO | 0.00 | $127.72 | -$632.97K | SELL-OPTIONS | 0.00% | 1.11M | Apr 08 | ||
Apr 10, 2024 | — | 0.00 | $127.82 | -$6.22M | SELL-OPTIONS | 0.00% | 841.27K | Apr 08 | ||
Apr 05, 2024 | PRES., R&D, AND CMO | 0.00 | $126.68 | -$17.32M | SELL-OPTIONS | 0.00% | 1.11M | Apr 03 - Apr 05 | ||
Apr 05, 2024 | DIRECTOR | 0.00 | $126.69 | -$17.29M | SELL-OPTIONS | 0.00% | 841.27K | Apr 03 - Apr 05 | ||
Apr 03, 2024 | — | 0.00 | $160.70 | -$2.13M | SELL-OPTIONS | 0.00% | 10.30K | Apr 01 | ||
Apr 03, 2024 | DIRECTOR | 0.00 | $163.54 | -$5.80M | SELL-OPTIONS | 0.00% | 1.20K | Apr 01 - Apr 02 | ||
Apr 03, 2024 | DIRECTOR | 0.00 | $177.60 | -$4.90M | SELL-OPTIONS | 0.00% | 1.20K | Apr 01 - Apr 02 | ||
Dec 18, 2023 | SENIOR VP, CHIEF PHARMA DEV. | 0.00 | $161.71 | -$590.32K | SELL-OPTIONS | 0.00% | 5.67K | Dec 14 - Dec 15 | ||
Dec 14, 2023 | DIRECTOR | 101.79K | $221.20 | $22.52M | BUY | 6.02% | 1.79M | Dec 13 - Dec 14 | ||
Dec 14, 2023 | DIRECTOR | 34.58K | $218.31 | $7.55M | BUY | 2.08% | 1.70M | Dec 12 | ||
Dec 14, 2023 | SENIOR VP, CHIEF PHARMA DEV. | 0.00 | $155.37 | -$512.60K | SELL-OPTIONS | 0.00% | 5.67K | Dec 12 - Dec 13 | ||
Dec 06, 2023 | SVP AND GENERAL COUNSEL | 0.00 | $152.58 | -$388.11K | SELL-OPTIONS | 0.00% | 15.53K | Dec 04 - Dec 05 | ||
Dec 01, 2023 | SVP AND GENERAL COUNSEL | 0.00 | $137.62 | -$894.23K | SELL-OPTIONS | 0.00% | 15.53K | Nov 29 - Nov 30 | ||
Nov 21, 2023 | DIRECTOR | 64.35K | $188.47 | $12.13M | BUY | 4.01% | 1.67M | Nov 21 | ||
Nov 21, 2023 | DIRECTOR | 67.08K | $178.11 | $11.95M | BUY | 4.35% | 1.61M | Nov 17 - Nov 20 | ||
Nov 15, 2023 | DIRECTOR | 49.39K | $158.13 | $7.81M | BUY | 3.30% | 1.55M | Nov 14 - Nov 15 | ||
Nov 15, 2023 | DIRECTOR | 107.50K | $146.99 | $15.80M | BUY | 7.72% | 1.50M | Nov 13 - Nov 14 | ||
Mar 02, 2023 | SENIOR VP, CHIEF PHARMA DEV. | 0.00 | $180.58 | -$1.85M | SELL-OPTIONS | 0.00% | 5.67K | Feb 28 - Mar 01 | ||
Jan 19, 2023 | DIRECTOR | 0.00 | $198.09 | -$4.28M | SELL-OPTIONS | 0.00% | 9.10K | Jan 17 | ||
Jan 06, 2023 | SVP AND GENERAL COUNSEL | 0.00 | $187.36 | -$2.48M | SELL-OPTIONS | 0.00% | 530.00 | Jan 03 | ||
Dec 28, 2022 | SVP AND GENERAL COUNSEL | 0.00 | $182.98 | -$1.28M | SELL-OPTIONS | 0.00% | 530.00 | Dec 23 | ||
Dec 28, 2022 | CHIEF COMMERCIAL OFFICER | 0.00 | $167.20 | -$6.42M | SELL-OPTIONS | 0.00% | 0.00 | Dec 23 | ||
Aug 19, 2020 | — | -30.00K | $109.74 | -$3.29M | SELL | -19.45% | 124.25K | Aug 17 - Aug 19 | ||
Aug 19, 2020 | — | -30.00K | $109.74 | -$3.29M | SELL | -18.42% | 132.88K | Aug 17 - Aug 19 |
FAQ
L'insider trading è legale?
L'insider trading è legale a condizione che gli insider segnalino le loro operazioni alla SEC. Il trading illegale di titoli si verifica quando l'insider viola un dovere fiduciario o non segnala le sue operazioni.
Quali sono alcuni esempi di manipolazione del mercato?
L'insider trading, gli schemi di pump and dump, il front running e i wash trade sono tutti esempi di manipolazione del mercato. Gli investitori che seguono i movimenti delle attività degli insider dovrebbero riflettere attentamente sul motivo per cui questi insider stanno negoziando le loro azioni prima di procedere.
Sfoglia insider trading su tutte le azioni.